These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis. O'Flynn RP; Shutack JG; Rosenberg H; Fletcher JE Anesthesiology; 1994 Jun; 80(6):1228-33. PubMed ID: 8010468 [TBL] [Abstract][Full Text] [Related]
9. [Malignant hyperthermia. I. Observations in connection with its pathogenesis and course (author's transl)]. Plötz J; Braun J; Gericke B Anaesthesist; 1980 Feb; 29(2):89-93. PubMed ID: 7377528 [TBL] [Abstract][Full Text] [Related]
10. Sudden death due to malignant hyperthermia. Pamukcoglu T Am J Forensic Med Pathol; 1988 Jun; 9(2):161-2. PubMed ID: 3381797 [TBL] [Abstract][Full Text] [Related]
11. [Extra-cardial rise of the CPK in the screening of urgent diagnostic (among others, a case of anaesthesia induced myoglobinuria and a case of malignant hypertermia) (author's transl)]. Bernhardt D; Hörder MH Med Klin; 1977 Nov; 72(46):1967-71. PubMed ID: 927298 [TBL] [Abstract][Full Text] [Related]
12. Masseter spasm with anesthesia: incidence and implications. Schwartz L; Rockoff MA; Koka BV Anesthesiology; 1984 Dec; 61(6):772-5. PubMed ID: 6507932 [No Abstract] [Full Text] [Related]
13. The work of the Leeds Malignant Hyperpyrexia Unit, 1971-84. Ellis FR; Halsall PJ; Harriman DG Anaesthesia; 1986 Aug; 41(8):809-15. PubMed ID: 3752463 [TBL] [Abstract][Full Text] [Related]
14. Central core disease and malignant hyperthermia syndrome. Frank JP; Harati Y; Butler IJ; Nelson TE; Scott CI Ann Neurol; 1980 Jan; 7(1):11-7. PubMed ID: 7362206 [TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of malignant hyperthermia susceptibility. 2. Anesthesia for muscle biopsy. Differential diagnosis in negative test results]. Breucking E; Mortier W Anaesthesist; 1993 Oct; 42(10):684-90. PubMed ID: 8250202 [TBL] [Abstract][Full Text] [Related]
16. Pathology of malignant hyperpyrexia. Br Med J; 1973 Feb; 1(5848):249. PubMed ID: 4685313 [No Abstract] [Full Text] [Related]
17. Should we use muscle biopsy to diagnose malignant hyperthermia susceptibility? Larach MG Anesthesiology; 1993 Jul; 79(1):1-4. PubMed ID: 8342796 [No Abstract] [Full Text] [Related]
18. Halothane-succinylcholine induced masseter spasm: indicative of malignant hyperthermia susceptibility? Flewellen EH; Nelson TE Anesth Analg; 1984 Jul; 63(7):693-7. PubMed ID: 6731899 [No Abstract] [Full Text] [Related]